Dr Ximena Lopez joins Ethics Talk to discuss her article, coauthored with Antonio D. Garcia: “How Cisgender Clinicians Can Help Prevent Harm During Encounters With Transgender Patients.”
Targeted dosing to treat pediatric inflammatory bowel disease is challenging because dosing guidelines are based on data gathered from adult subjects of clinical trials. Patients’ families and health care organizations also incur high costs and must try to balance potential benefits against risks of ongoing monitoring.
AMA J Ethics. 2018;20(9):E841-848. doi:
10.1001/amajethics.2018.841.